- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Based on the award-winning Wiley Encyclopedia of Chemical Biology published in 2008, this book explores the role of chemical biology in drug discovery and development. Comprising carefully selected reprints from the Encyclopedia as well as new contributions from leading scholars in the field, this book provides researchers in academia and industry with important information to aid in the development of novel agents to treat disease. This book is a top-notch guide and reference for anyone working in the areas of drug discovery and development.
Andere Kunden interessierten sich auch für
- Natural Products in Chemical Biology159,99 €
- Anthony K. CampbellIntracellular Calcium, 2 Volume Set328,99 €
- Chiral Drugs202,99 €
- Jerold ChunLysophospholipid Receptors186,99 €
- Robert A. CopelandEvaluation of Enzyme Inhibitors in Drug Discovery166,99 €
- Guoan LuoSystems Biology for Traditional Chinese Medicine224,99 €
- Daniel LednicerSteroid Chemistry at a Glance54,99 €
-
-
-
Based on the award-winning Wiley Encyclopedia of Chemical Biology published in 2008, this book explores the role of chemical biology in drug discovery and development. Comprising carefully selected reprints from the Encyclopedia as well as new contributions from leading scholars in the field, this book provides researchers in academia and industry with important information to aid in the development of novel agents to treat disease. This book is a top-notch guide and reference for anyone working in the areas of drug discovery and development.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 524
- Erscheinungstermin: 2. Oktober 2012
- Englisch
- Abmessung: 236mm x 157mm x 33mm
- Gewicht: 862g
- ISBN-13: 9781118101186
- ISBN-10: 1118101189
- Artikelnr.: 34447225
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 524
- Erscheinungstermin: 2. Oktober 2012
- Englisch
- Abmessung: 236mm x 157mm x 33mm
- Gewicht: 862g
- ISBN-13: 9781118101186
- ISBN-10: 1118101189
- Artikelnr.: 34447225
NATANYA CIVJAN, PhD, is a freelance editor with a doctorate in biochemistry. Formerly with John Wiley & Sons, she developed and edited the Wiley Encyclopedia of Chemical Biology and was part of the team responsible for the Wiley Interdisciplinary Reviews, which won top prizes in publishing from the American Publishers Awards for Professional and Scholarly Excellence.
Contributors xi PART I DRUG DISCOVERY AND DEVELOPMENT 1 1 The Role of
Chemical Biology in Drug Discovery 3 Andrew J. Pope 2 Computational
Approaches to Drug Discovery and Development 23 Honglin Li, Mingyue Zheng,
Xiaomin Luo, Weiliang Zhu, and Hualiang Jiang 3 Design and Selection of
Small Molecule Inhibitors 41 Jianwei Che, Yi Liu, and Nathanael S. Gray 4
Lead Optimization in Drug Discovery 65 Craig W. Lindsley, David Weaver,
Thomas M. Bridges, and J. Phillip Kennedy 5 Pharmacokinetics of Drug
Candidates 83 Ronald E. White 6 ADME Properties of Drugs 101 Li Di and
Edward H. Kerns 7 Drug Transport in Living Systems 115 Yael Elbaz and
Shimon Schuldiner 8 Blood-Brain Barrier: Considerations in Drug Development
and Delivery 133 David S. Miller and Brian T. Hawkins 9 Pharmacokinetic
Considerations: Methods and Systems of Controlled Drug Delivery 147 Zhong
Zuo and Vincent H. L. Lee 10 Pharmaceuticals: Natural Products and Natural
Product Models 165 Sheo B. Singh PART II CHEMICAL BIOLOGY TO UNDERSTAND AND
TARGET DISEASE 203 11 The Role of Chemical Biology in Understanding and
Treating Disease--Are Small Molecule "Correctors" the Way of the Future?
205 David Selwood 12 Anxiety Disorders 215 Miklos Toth 13 Chronic
Obstructive Pulmonary Disease (COPD) 245 Peter J. Barnes 14 Depression 267
Glen B. Baker and Nicholas D. Mitchell 15 Osteoarthritis 293 Marjolaine
Gosset, Jeremie Sellam, Claire Jacques, nd Francis Berenbaum 16 Human
Immunodeficiency Virus (HIV) 331 Joseph P. Vacca 17 Allergy and Asthma 341
Garry M. Walsh 18 Schizophrenia 357 Ferenc Martenyi 19 Protein Misfolding
and Disease 379 Johanna C. Scheinost, Grant E. Boldt, and Paul Wentworth 20
Protein Trafficking Diseases 401 Heidi M. Sampson and David Y. Thomas 21
Metabolic Diseases 419 Cynthia M. Arbeeny 22 Mitochondrial Medicine 445
Richard J. T. Rodenburg and Jan A. M. Smeitink 23 Lysosomal Disorders 461
Doug A. Brooks and Maria Fuller Index 483
Chemical Biology in Drug Discovery 3 Andrew J. Pope 2 Computational
Approaches to Drug Discovery and Development 23 Honglin Li, Mingyue Zheng,
Xiaomin Luo, Weiliang Zhu, and Hualiang Jiang 3 Design and Selection of
Small Molecule Inhibitors 41 Jianwei Che, Yi Liu, and Nathanael S. Gray 4
Lead Optimization in Drug Discovery 65 Craig W. Lindsley, David Weaver,
Thomas M. Bridges, and J. Phillip Kennedy 5 Pharmacokinetics of Drug
Candidates 83 Ronald E. White 6 ADME Properties of Drugs 101 Li Di and
Edward H. Kerns 7 Drug Transport in Living Systems 115 Yael Elbaz and
Shimon Schuldiner 8 Blood-Brain Barrier: Considerations in Drug Development
and Delivery 133 David S. Miller and Brian T. Hawkins 9 Pharmacokinetic
Considerations: Methods and Systems of Controlled Drug Delivery 147 Zhong
Zuo and Vincent H. L. Lee 10 Pharmaceuticals: Natural Products and Natural
Product Models 165 Sheo B. Singh PART II CHEMICAL BIOLOGY TO UNDERSTAND AND
TARGET DISEASE 203 11 The Role of Chemical Biology in Understanding and
Treating Disease--Are Small Molecule "Correctors" the Way of the Future?
205 David Selwood 12 Anxiety Disorders 215 Miklos Toth 13 Chronic
Obstructive Pulmonary Disease (COPD) 245 Peter J. Barnes 14 Depression 267
Glen B. Baker and Nicholas D. Mitchell 15 Osteoarthritis 293 Marjolaine
Gosset, Jeremie Sellam, Claire Jacques, nd Francis Berenbaum 16 Human
Immunodeficiency Virus (HIV) 331 Joseph P. Vacca 17 Allergy and Asthma 341
Garry M. Walsh 18 Schizophrenia 357 Ferenc Martenyi 19 Protein Misfolding
and Disease 379 Johanna C. Scheinost, Grant E. Boldt, and Paul Wentworth 20
Protein Trafficking Diseases 401 Heidi M. Sampson and David Y. Thomas 21
Metabolic Diseases 419 Cynthia M. Arbeeny 22 Mitochondrial Medicine 445
Richard J. T. Rodenburg and Jan A. M. Smeitink 23 Lysosomal Disorders 461
Doug A. Brooks and Maria Fuller Index 483
Contributors xi PART I DRUG DISCOVERY AND DEVELOPMENT 1 1 The Role of
Chemical Biology in Drug Discovery 3 Andrew J. Pope 2 Computational
Approaches to Drug Discovery and Development 23 Honglin Li, Mingyue Zheng,
Xiaomin Luo, Weiliang Zhu, and Hualiang Jiang 3 Design and Selection of
Small Molecule Inhibitors 41 Jianwei Che, Yi Liu, and Nathanael S. Gray 4
Lead Optimization in Drug Discovery 65 Craig W. Lindsley, David Weaver,
Thomas M. Bridges, and J. Phillip Kennedy 5 Pharmacokinetics of Drug
Candidates 83 Ronald E. White 6 ADME Properties of Drugs 101 Li Di and
Edward H. Kerns 7 Drug Transport in Living Systems 115 Yael Elbaz and
Shimon Schuldiner 8 Blood-Brain Barrier: Considerations in Drug Development
and Delivery 133 David S. Miller and Brian T. Hawkins 9 Pharmacokinetic
Considerations: Methods and Systems of Controlled Drug Delivery 147 Zhong
Zuo and Vincent H. L. Lee 10 Pharmaceuticals: Natural Products and Natural
Product Models 165 Sheo B. Singh PART II CHEMICAL BIOLOGY TO UNDERSTAND AND
TARGET DISEASE 203 11 The Role of Chemical Biology in Understanding and
Treating Disease--Are Small Molecule "Correctors" the Way of the Future?
205 David Selwood 12 Anxiety Disorders 215 Miklos Toth 13 Chronic
Obstructive Pulmonary Disease (COPD) 245 Peter J. Barnes 14 Depression 267
Glen B. Baker and Nicholas D. Mitchell 15 Osteoarthritis 293 Marjolaine
Gosset, Jeremie Sellam, Claire Jacques, nd Francis Berenbaum 16 Human
Immunodeficiency Virus (HIV) 331 Joseph P. Vacca 17 Allergy and Asthma 341
Garry M. Walsh 18 Schizophrenia 357 Ferenc Martenyi 19 Protein Misfolding
and Disease 379 Johanna C. Scheinost, Grant E. Boldt, and Paul Wentworth 20
Protein Trafficking Diseases 401 Heidi M. Sampson and David Y. Thomas 21
Metabolic Diseases 419 Cynthia M. Arbeeny 22 Mitochondrial Medicine 445
Richard J. T. Rodenburg and Jan A. M. Smeitink 23 Lysosomal Disorders 461
Doug A. Brooks and Maria Fuller Index 483
Chemical Biology in Drug Discovery 3 Andrew J. Pope 2 Computational
Approaches to Drug Discovery and Development 23 Honglin Li, Mingyue Zheng,
Xiaomin Luo, Weiliang Zhu, and Hualiang Jiang 3 Design and Selection of
Small Molecule Inhibitors 41 Jianwei Che, Yi Liu, and Nathanael S. Gray 4
Lead Optimization in Drug Discovery 65 Craig W. Lindsley, David Weaver,
Thomas M. Bridges, and J. Phillip Kennedy 5 Pharmacokinetics of Drug
Candidates 83 Ronald E. White 6 ADME Properties of Drugs 101 Li Di and
Edward H. Kerns 7 Drug Transport in Living Systems 115 Yael Elbaz and
Shimon Schuldiner 8 Blood-Brain Barrier: Considerations in Drug Development
and Delivery 133 David S. Miller and Brian T. Hawkins 9 Pharmacokinetic
Considerations: Methods and Systems of Controlled Drug Delivery 147 Zhong
Zuo and Vincent H. L. Lee 10 Pharmaceuticals: Natural Products and Natural
Product Models 165 Sheo B. Singh PART II CHEMICAL BIOLOGY TO UNDERSTAND AND
TARGET DISEASE 203 11 The Role of Chemical Biology in Understanding and
Treating Disease--Are Small Molecule "Correctors" the Way of the Future?
205 David Selwood 12 Anxiety Disorders 215 Miklos Toth 13 Chronic
Obstructive Pulmonary Disease (COPD) 245 Peter J. Barnes 14 Depression 267
Glen B. Baker and Nicholas D. Mitchell 15 Osteoarthritis 293 Marjolaine
Gosset, Jeremie Sellam, Claire Jacques, nd Francis Berenbaum 16 Human
Immunodeficiency Virus (HIV) 331 Joseph P. Vacca 17 Allergy and Asthma 341
Garry M. Walsh 18 Schizophrenia 357 Ferenc Martenyi 19 Protein Misfolding
and Disease 379 Johanna C. Scheinost, Grant E. Boldt, and Paul Wentworth 20
Protein Trafficking Diseases 401 Heidi M. Sampson and David Y. Thomas 21
Metabolic Diseases 419 Cynthia M. Arbeeny 22 Mitochondrial Medicine 445
Richard J. T. Rodenburg and Jan A. M. Smeitink 23 Lysosomal Disorders 461
Doug A. Brooks and Maria Fuller Index 483